UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News:
Orexo (STO:ORX) today announces the invitation of analysts, investors and media to an information meeting about Zubsolv™ (OX219), a product developed for treatment of opioid dependence, this coming Friday September 21.
Date: Friday, September 21 2012
Time: 10:00am-1:00pm (lunch included)
Place: ABG, Sundal Collier AB, Regeringsgatan 65, 5 floor, Stockholm
RSVP:
registration ASAP to asa.henriksson@abgsc.se
